Skip to main content
. 2017 May 19;8(5):146. doi: 10.3390/genes8050146

Figure 2.

Figure 2

Comparison of the prevalence of Human Leukocyte Antigen (HLA) DR risk-groups in the patients with early-onset diabetes before age five years (n = 233), and prior analyses of adolescent-onset T1D (n = 1445; data from [34]) and type 2 diabetes (T2D) patients (n = 109, data from [35]) with a local control population (n = 19,544, each ** p < 0.001).